The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis

24Citations
Citations of this article
55Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

It is well known that both recipient cells and donor nuclei demonstrate a mitotic advantage as observed in the traditional reprogramming with somatic cell nuclear transfer (SCNT). However, it is not known whether a specific mitotic factor plays a critical role in reprogramming. Here we identify an isoform of human bromodomain-containing 3 (BRD3), BRD3R (BRD3 with Reprogramming activity), as a reprogramming factor. BRD3R positively regulates mitosis during reprogramming, upregulates a large set of mitotic genes at early stages of reprogramming, and associates with mitotic chromatin. Interestingly, a set of the mitotic genes upregulated by BRD3R constitutes a pluripotent molecular signature. The two BRD3 isoforms display differential binding to acetylated histones. Our results suggest a molecular interpretation for the mitotic advantage in reprogramming and show that mitosis may be a driving force of reprogramming.

Cite

CITATION STYLE

APA

Shao, Z., Zhang, R., Khodadadi-Jamayran, A., Chen, B., Crowley, M. R., Festok, M. A., … Hu, K. (2016). The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis. Nature Communications, 7. https://doi.org/10.1038/ncomms10869

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free